Michael Linnebank

6.8k total citations
141 papers, 3.3k citations indexed

About

Michael Linnebank is a scholar working on Rheumatology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Michael Linnebank has authored 141 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Rheumatology, 39 papers in Pathology and Forensic Medicine and 30 papers in Neurology. Recurrent topics in Michael Linnebank's work include Folate and B Vitamins Research (53 papers), Multiple Sclerosis Research Studies (29 papers) and Metabolism and Genetic Disorders (21 papers). Michael Linnebank is often cited by papers focused on Folate and B Vitamins Research (53 papers), Multiple Sclerosis Research Studies (29 papers) and Metabolism and Genetic Disorders (21 papers). Michael Linnebank collaborates with scholars based in Switzerland, Germany and Netherlands. Michael Linnebank's co-authors include Alexander Semmler, Michael Weller, Susanna Moskau, Björn Zörner, Thomas Klockgether, Uwe Schlegel, Linard Filli, Hendrik Pels, Roland Martinꝉ and Heike Kölsch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Michael Linnebank

140 papers receiving 3.2k citations

Peers

Countries citing papers authored by Michael Linnebank

Since Specialization

Citations

This map shows the geographic impact of Michael Linnebank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Linnebank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Linnebank more than expected).

Fields of papers citing papers by Michael Linnebank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Linnebank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Linnebank. The network helps show where Michael Linnebank may publish in the future.

Co-authorship network of co-authors of Michael Linnebank

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Linnebank. A scholar is included among the top collaborators of Michael Linnebank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Linnebank. Michael Linnebank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years 2018 ·Journal of Neurology ·(unknown), Linard Filli, (unknown), (unknown), Björn Zörner, Peter Brugger, Michael Linnebank	36
2	Minimum toe clearance: probing the neural control of locomotion 2017 ·Scientific Reports ·Tim Killeen, Chris Awai Easthope, László Demkó, Linard Filli, (unknown), Michael Linnebank, Armin Curt, Björn Zörner, Marc Bolliger	42
3	Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology 2017 ·Acta Neuropathologica ·Benjamin Victor Ineichen, (unknown), (unknown), Nicolas Good, (unknown), (unknown), Julia Kaiser, Marc P. Schneider, Björn Zörner, Roland Martinꝉ, Michael Linnebank, Martin E. Schwab	44
4	The relevance of cortical lesions in patients with multiple sclerosis 2016 ·BMC Neurology ·(unknown), Tobias Pflugshaupt, Ladina Bezzola, Katja Reuter, (unknown), Bernhard Schuknecht, Peter Brugger, Michael Linnebank	19
5	Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion 2016 ·Expert Opinion on Pharmacotherapy ·Nikolaos Grigoriadis, Michael Linnebank, Nektaria Alexandri, (unknown), Günther F.L. Hofbauer	3
6	Random number generation deficits in patients with multiple sclerosis: Characteristics and neural correlates 2016 ·Cortex ·(unknown), Tobias Pflugshaupt, Andreas Buchmann, Ladina Bezzola, Katja Reuter, Bernhard Schuknecht, (unknown), Michael Linnebank, Peter Brugger	12
7	Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism 2013 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Alexander Semmler, (unknown), Birgit Stoffel‐Wagner, Christian E. Elger, Michael Linnebank	17
8	Alterations of Homocysteine Serum Levels during Alcohol Withdrawal Are Influenced by Folate and Riboflavin: Results from the German Investigation on Neurobiology in Alcoholism (GINA) 2012 ·Alcohol and Alcoholism ·(unknown), Michael Linnebank, Alexander Semmler, Marc Muschler, Annemarie Heberlein, Helge Frieling, Birgit Stoffel‐Wagner, Johannes Kornhuber, Markus Banger, Stefan Bleich, Thomas Hillemacher	18
9	Autoimmune Myasthenia Gravis after Sternal Fracture 2012 ·Case Reports in Neurology ·Jens A. Petersen, Hans H. Jung, Michael Weller, Michael Linnebank	2
10	Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid 2012 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Desirée E.C. Smith, Yvo M. Smulders, Henk J. Blom, Julius Popp, Frank Jessen, Alexander Semmler, (unknown), Michael Linnebank	23
11	The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis 2010 ·Amyotrophic Lateral Sclerosis ·Peter Kühnlein, Hans H. Jung, (unknown), Salla Keskitalo, Benjamin Victor Ineichen, Ilijas Jelčić, Jens A. Petersen, Alexander Semmler, Michael Weller, Albert C. Ludolph, Michael Linnebank	8
12	Long‐term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma 2009 ·Annals of Neurology ·(unknown), Hendrik Pels, (unknown), Klaus Fließbach, Axel Glasmacher, Andreas Engert, Marcel Reiser, Volker Diehl, Marlies Vogt‐Schaden, Gerlinde Egerer, Gabriele Schackert, Heinz Reichmann, Frank Kroschinsky, U. Bode, Ulrich Herrlinger, Michael Linnebank, Martina Deckert, Rolf Fimmers, Ingo G.H. Schmidt‐Wolf, Uwe Schlegel	82
13	Therapy of X-linked adrenoleukodystrophy 2008 ·Expert Review of Neurotherapeutics ·Alexander Semmler, Wolfgang Köhler, Hans H. Jung, Michael Weller, Michael Linnebank	31
14	Polymorphisms of Homocysteine Metabolism Are Associated with Intracranial Aneurysms 2008 ·Cerebrovascular Diseases ·Alexander Semmler, Michael Linnebank, Dietmar Krex, Anika Götz, Susanna Moskau, Andreas Ziegler, Matthias Simon	16
15	Genetic association study of the P‐type ATPase ATP13A2 in late‐onset Parkinson's disease 2008 ·Movement Disorders ·Aleksandar Raković, Barbara Stiller, Ana Djarmati, Antònia Flaquer, Jan Freudenberg, (unknown), Michael Linnebank, Vladimir Kostić, Katja Lohmann, Sebastian Paus, Peter Nürnberg, Christian Kubisch, Christine Klein, Ullrich Wüllner, Alfredo Ramı́rez	10
16	Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate 2007 ·International Journal of Clinical Pharmacology and Therapeutics ·Albert J. Becker, Sandra Vezmar, Michael Linnebank, Hendrik Pels, U. Bode, Uwe Schlegel, Ulrich Jaehde	23
17	Acute Methotrexate-Induced Encephalopathy - Causal Relation to Homozygous Allelic State for MTR c.2756A>G (D919G)? 2007 ·Journal of Chemotherapy ·Michael Linnebank, S. Malessa, (unknown), (unknown), Hendrik Pels, Thomas Klockgether, Uwe Schlegel	13
18	Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe 2006 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Alexander Semmler, Robert W. Stein, (unknown), Sergei M. Danilov, Thomas Klockgether, Michael Linnebank	7
19	Orale Vitamin-B12-Substitution bei funikulärer Myelose 2006 ·Der Nervenarzt ·(unknown), (unknown), Wolfgang Herrmann, (unknown), Thomas Klockgether, Michael Linnebank	1
20	The cystathionine ?-synthase (CBS) mutation c.1224-2A>C in Central Europe: Vitamin B6 nonresponsiveness and a common ancestral haplotype 2004 ·Human Mutation ·Michael Linnebank, Miroslav Janošı́k, Viktor Kožich, Ewa Pronicka, Jolanta Kubalska, Jitka Sokolová, (unknown), (unknown), (unknown), Thomas Klockgether, Jan P. Kraus, Hans Georg Koch	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact